Skip to main content
SpringerLink
Log in

Procalcitonin in febrile neutropenia—timing is important

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ahn S, Lee Y-S, Lim KS, Lee J-L (2013) Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia. Support Care Cancer 21:2303–2308

    Article  PubMed  Google Scholar 

  2. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E et al (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115(1):53–57

    Article  CAS  PubMed  Google Scholar 

  3. de Bont ES, Vellenga E, Swaanenburg J, Kamps W (2000) Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 28(6):398–400

    Article  PubMed  Google Scholar 

  4. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M et al (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79(6):1605–1608

    CAS  PubMed  Google Scholar 

  5. Robinson JO, Lamoth F, Bally F, Knaup M, Calandra T, Marchetti O (2011) Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever? PloS one 6(4):e18886

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

This study was not funded. The authors declare no conflict of interest. We, the authors, have access to the primary data and have no objections if the editors wish to look at the primary data.

Author information

Authors and Affiliations

  1. Department of Infectious Diseases, Singapore General Hospital, The Academia, 20 College Road, Singapore, 169856, Singapore

    Ban Hock Tan

  2. Department of Haematology, Singapore General Hospital, Singapore, Singapore

    May Ee Png & Gee Chuan Wong

  3. Clinical Biochemistry Section, Department of Pathology, Singapore General Hospital, Singapore, Singapore

    Chin Pin Yeo

Authors
  1. Ban Hock Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. May Ee Png
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chin Pin Yeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gee Chuan Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ban Hock Tan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, B.H., Png, M.E., Yeo, C.P. et al. Procalcitonin in febrile neutropenia—timing is important. Support Care Cancer 22, 583–584 (2014). https://doi.org/10.1007/s00520-013-2078-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-013-2078-y

Keywords

Search

Navigation